The Ethics of Innovation: Disability, Technology, and Reproductive Justice – with Katie Hasson
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson],
Disability Deep Dive
| 07. 24. 2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into the ethical concerns surrounding genetic technologies, the medical vs. social model of disability, and the risk of eugenics in current bioethical practices. Katie also highlights the Center's work in ensuring social justice and equity in biotechnologies, and emphasizing the importance of including disabled voices in policy discussions. The episode concludes with a discussion on the documentary 'Fixed: The Science/Fiction of Human Enhancement,' which examines the impact of biotechnology on the disabled community.
Episode Transcript
Jodi Beckstine (00:01):
Want to talk and explore how disability science and ethics collide in today's tech-driven world? We're diving headfirst into the ethics of innovation on this episode of Disability Deep Dive.
Keith Casebonne (00:38):
Hello, listeners. We are really glad you're here. I'm Keith.
Jodi Beckstine (00:41):
And I'm Jody. Welcome back to Disability Deep Dive.
Keith Casebonne (00:45):
Today's episode is called the...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...